Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland

Journal of Viral Hepatitis

Volumn 17, Issue 6, 2010, Pages 444-452

  Grabarczyk, P ^a   Garmiri, P ^b   Liszewski, G ^a   Doucet, D ^c   Sulkowska, E ^a   Brojer, E ^a   Allain, J P ^b  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c GSK   (Belgium)

Author keywords

Blood donors; Genotypes; Hepatitis B virus; Hepatitis B virus surface antigene; Mutants

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYDROPHILICITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEROLOGY; VIRUS LOAD; VIRUS STRAIN; ADOLESCENT; BLOOD; BLOOD DONOR; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETIC VARIABILITY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; POLAND; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIRAL LOAD; VIRAL PROTEINS; YOUNG ADULT;

EID: 77952269637     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01192.x     Document Type: Article

References (33)

1. Okamoto H, Imai M, Kametanio M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in 54-year-old woman who contracted the infection through materio-fetal transmission. Jap J Exp Med 1987 57 : 231 236.
2. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY. Molecular evolution of hepatitis B virus over 25 years. J Virol 2006 80 : 10307 10314.
3. Allain J-P. Epidemiology of hepatitis B virus and genotype. J Clin Virol 2006 36 (Suppl. 1 S12 S17.
4. Okamoto H, Tsuda F, Akahane Y et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994 68 : 8102 8110.
5. Carman WF, Jacyna MR, Hadziyannis S et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989 2 : 588 591.
6. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996 70 : 5845 5851.
7. Gunther S, Piwon N, Will H. Wild-type levels of pregenomic RNA and replication but reduced PC RNA and e-antigen synthesis of hepatitis B virus with C(1653) to T, A(1762) to T and G(1764) to A mutations in the core promoter. J Gen Virol 1998 79 : 375 380.
8. Sterneck M, Kalinina T, Gunther S et al. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 1998 28 : 1390 1397.
9. Jammeh S, Tavner F, Watson R, Thomas H, Karayiannis P. Effect of basal core promoter and precore mutations on hepatitis B virus replication. J Gen Virol 2008 89 : 901 909.
10. Echevaria JM, Avellon A. Hepatitis B virus genetic diversity. J Med Virol 2006 78 : S36 S42.
11. Magdzik WW. Hepatitis epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine 2000 18 (Suppl 1 S13 S16.
12. Grabarczyk P, Seyfried H, Brojer E et al. HBsAg detection in blood donors in Poland, 1995-2004. J Transf Med 2009 1 (1 20 25.
13. Kuśmierczyk J, Zatorska J, Ras J et al. Prevalence of anti-HBc anibodies in blood donors in the South region of Poland. Vox Sang 2006 9 (Suppl 3 56.
14. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain J-P, Ltowska M. Characterization of HBV DNA positive/HBsAg negative blood donors identified in the Polish NAT screening program. Hepatology 2006 44 : 1666 1674.
15. Candotti D, Grabarczyk P, Ghiazza P et al. Epidemiology and molecular characterization of occult hepatitis B infection (OBI) in European asymptomatic blood donors. J Hepatol 2008 49 : 537 547.
16. Zahn A, Li Ch, Danso K et al. Molecular characterization of occult hepatitis B virus genotype E-infected subjects. J Gen Virol 2008 89 : 409 418.
17. Candotti D, Opare-Sem O, Rezvan H, Sarkodie F, Allain J-P. Molecular and serological characterisation of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase. J Viral Hep 2006 13 : 715 724.
18. Bartholomeusz A, Locarnini S. Hepatitis B virus mutations associated with antiviral therapy. J Med Virol 2006 78 : S52 S55.
19. Warner N, Locarnini S, Kuiper M et al. The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. Antimicrob Agents Chemother 2007 51 (7 2285 2292.
20. Bielawski KP, Charmuszko U, Dybikowska A, Stalke P, Podhajska AJ. Genetic variability of hepatitis B virus isolates in Poland. Viral Genes 2006 33 : 77 86.
21. Deterding K, Constantinescu I, Nedelcu FD et al. Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol 2008 80 : 1707 1711.
22. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBv DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004 44 : 1332 1339.
23. Allain J-P, Sarkodie F, Candotti D, Opare-Sem O. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Transfusion 2005 45 : 1039 1040.
24. Gerlich WH, Glebe D, Schusttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007 14 (Suppl 1 16 21.
25. Koppelman MHGM, Sjerps MC, Reesink HW, Cuypers HTM. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection. Vox Sang 2005 89 : 193 200.
26. Biswas R, Tabor E, Hsia CC et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 798.
27. Magdzik W, Czarkowski MP. Coverage of vaccination against hepatitis B in Poland in 2004. Przegl Epidemiol 2006 60 (2 185 192.
28. Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990 11 : 325 329.
29. Lada O, Benhamou Y, Poynard T, Thibault V. Coexistance of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol 2006 80 : 2968 2975.
30. Margeridon S, Lachaux A, Trepo C, Zoulim F, Kay A. A quasi-monoclonal anti-HBs response can lead to immune escape of "wild-type" hepatitis B virus. J Gen Virol 2005 86 : 1687 1693.
31. Davidson F, Lycett C, Sablon E, Petrik J, Dow BC. Hepatitis B virus genotypes and precore mutations in Scottish blood donors. Vox Sang 2008 88 : 87 92.
32. Kao J, Ch P, Lai M, Chen D. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 2002 40 : 22 25.
33. Hsu Hy, Chang Mh, Nu YH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute and chronic infections despite immunoprophylaxis. Hepatology 1997 26 : 786 791.